MED 7710 Patient III Assessment Plan

MED 7710 Patient III
Phase 3, Class of 2026

Assessment Plan
The assessment plan sets out the principles and key elements used to assess the learner’s performance in an accurate, consistent, and objective manner for MED 7710 Patient III.

The Patient III course has learners build on their knowledge obtained from the themes presented in Phase I and II and encounter new themes with both horizontal and vertical integration of physician competencies, clinical skills and basic and clinical sciences as they relate to common clinical encounters and patient symptoms.

Learners will learn in the context of a person as part of a family in a community. Learners will begin to examine their future roles as professionals in our health care system.

To pass the course, a learner must:    

  • Pass at least 9 of the 10 written examinations,
  • Achieve an average mark of  ≥70 based on the weighted final marks across the 10 examinations and the Palliative Care group assignment,
  • Complete and submit all assignments and assessments by the due date, and
  • Attend all sessions designated as mandatory and complete any associated activities.

Exam and assignment deferrals will only be approved by the Phase Lead under exceptional circumstances, see Exam Deferral Policy.

Promotion regulations:

  • Even if a learner has passed all examinations and assignments, a learner may be required to repeat the Phase or withdraw conditionally or unconditionally from the program (see section 5.3 in the University calendar) if there are significant concerns about a learner’s performance (as communicated to the learner by the Phase Lead). Examples may include, but are not limited to, late assignments or missed mandatory sessions without proper deferral process, lapses in professionalism, recurrent reassessment exams.
  • As outlined in Section 5.2 of the Regulations for the Degree of Doctor of Medicine in the University calendar, learners with a Fail grade in any course cannot be promoted to the next Phase.
  • As outlined in the MD program objectives, the Faculty of Medicine at Memorial University values professionalism as a core competency and a requirement of the MD program. Recognizing that medical learners are developing their professional identity, professionalism lapses will be remediated where possible and appropriate. Unsuccessful remediation will result in failure of the Phase.  Professionalism lapses may render a learner incompatible with continuation in the MD program (as outlined in the Memorial University Calendar Regulation 10.5 Promotion).

Learners will be assessed with both formative and summative assessment methods throughout the course. Learners will receive their grades from the Undergraduate Medical Education (UGME) office via One45.

Original work, completed wholly by the learner, is expected to be submitted in this course. The use of an artificial intelligence tool like chatGPT is not permitted.

Formative assessments do not count towards the final grade and are intended to help learners monitor their learning.  Formative assessment will consist of weekly online quizzes. Learners are also expected to review and learn from their performance on the summative assessments that occur throughout the course. The process for review of summative examinations is detailed in Section H.2 of the Summative Assessment Procedure for Phases 1-3.

Summative assessments include ten online written multiple-choice question (MCQ) examinations, following each of the course themes and one Palliative Care group assignment. Each of these summative assessments is graded and contributes to the final summative mark that the learner will receive for the course.

The course includes mandatory learning sessions, listed in the respective section below. Learners must participate in these sessions and complete any associated exercises. As outlined in the Protected Time and Duty Hours Policy, learners may request leave if they are unable to attend a mandatory learning session.
The contribution of marks from each summative assessment towards the final course grade is as follows:

Examination 1: Weakness and Abnormal Movements


Examination 2: Cognitive Impairment and Mood Disturbances


Examination 3: Hormones and Blood Disorders


Examination 4: Pregnancy, Delivery and Newborns  


Examination 5: Genetic Disorders, Growth and Development


Examination 6: Pelvic Pain and Masses             


Examination 7: Syncope and Chest Pain


Examination 8: Renal Failure and Diabetes


Examination 9: Trauma and Emergencies     


Examination 10: Lymphadenopathy, Splenomegaly

and Cancer/Care of the Elderly/Pain Management


Palliative Care group assignment                                                   




The final grade and overall course mark will be compiled at the end of the Phase. If the Burr method is used to determine the pass mark for a summative examination, the percent-correct score for each learner will be converted to a scaled score. For the scaled score, the pass mark as determined by the Burr method is set to 70 and percent-correct scores are converted using linear transformation. Scaled scores will then be used to calculate the overall course mark.
(a) Summative written examinations occur on the dates listed below. Learners may refer to the schedule on Brightspace regarding the instructional hours in each theme.



Exam date

Reassessment date

Examination 1: Weakness and Abnormal Movements


September 25, 2023

October 5, 2023

Examination 2: Cognitive Impairment and Mood Disturbances


October 16, 2023

October 26, 2023

Examination 3: Hormones and Blood Disorders


November 9, 2023

November 23, 2023

Examination 4: Pregnancy, Delivery and Newborns


December 15, 2023

January 4, 2024

Examination 5: Genetic Disorders, Growth and Development


January 29, 2024

February 8, 2024

Examination 6: Pelvic Pain and Masses


February 15, 2024

February 29, 2024

Examination 7: Syncope and Chest Pain


March 4, 2024

March 14, 2024

Examination 8: Renal Failure and Diabetes


March 25, 2024

April 8, 2024

Examination 9: Trauma and Emergencies


April 19, 2024

May 2, 2024

Examination 10: Lymphadenopathy, Splenomegaly and Cancer/Care of the Elderly/ Pain Management


May 10, 2024

May 23, 2024 (1/2 class)

June 6, 2024 (1/2 class)

Learners achieving a percent-correct score of 70% or higher on a written summative examination will receive a pass. If one or more learners achieve a percent-correct score of less than 70% on a summative written examination, the pass mark for the examination will be determined using the Burr method1. Using this approach, the upper limit of the pass mark is set to the median percent-correct score of the class minus 10%, or 70%, whichever is lower. The pass mark is identified by applying this upper limit to the cumulative frequency curve of the achieved percent-correct scores of the class.

(b) Palliative Care Group Assignment

The Palliative Care sessions will be assessed with one written group assignment. Learners will work in groups to discuss case studies and write-up their reflections. The mark assigned to the group for the assignment will be applied to each learner in the group. The assignment will be graded on a pass/fail basis. Details and the assessment rubric will be available on Brightspace (D2L).

The assignment is 1000-1200 words in length.
Due date: May 24, 2024

Mandatory Learning Sessions

Mandatory learning sessions are defined as sessions that require learners to attend in order to achieve the learning objectives. Sessions are designated mandatory if they meet one or more of the following criteria:

  • Provide an introduction or overview of learner expectations for the MD program, phase or course;
  • Involve application of clinical decision-making skills such as tutorials, case-based learning and laboratories; 
  • Include an assessment component;
  • Involve interactivity such as integrated learning sessions, interprofessional education sessions, guest speakers or patient volunteers; and/or
  • Provide support and/or counseling to promote learner well-being and success.

Mandatory learning session


Abdominal Pain Tutorial

As scheduled in Brightspace.

Abnormal ECG Arrhythmia Tutorial

Abnormal ECG ECK Ischemic Heart Disease Tutorial

Acute Kidney Injury Tutorial

Approach to Anemia Tutorial

Comprehensive Geriatric Assessment

Cytogenetics Tutorial

Diabetes Tutorial

Diabetes Workshop

Hematologic Neoplasia 2

Hematologic Neoplasia 3

Hypertension Tutorial

Integration of Genetic Concepts 1

Integration of Genetic Concepts 2

Lipid Disorder Tutorial

Living with Genetic Diseases Tutorial

Mood Disorder Tutorial

Myocardial Infarction Tutorial

Nervous System Histology Lab

Placenta and Fetal Membranes Lab

Pedigree Analysis and Construction Tutorial

Pericardial Disease and Chest Pain Tutorial

Physiology of BF Tutorial and Demo

Pituitary and Adrenal Tutorial

Pituitary, Head and Neck Tutorial Histology

Psychotic and Anxiety Disorder Tutorial

Renal Problem Based Tutorial 1

Renal Problem Based Tutorial 2

Renal Problem Based Tutorial 3

Renal Problem Based Tutorial 4

Seizure Tutorial

Stroke Tutorial

Symptom Management Tutorial

Syncope Tutorial

Thyroid and Parathyroid Tutorial

Thyroid Disease Tutorial

Upper GI Bleeding Tutorial

Vision Lab


  • Reassessment will be required if a learner achieves a mark <70% or, if applicable, less than the pass mark on any one of the ten written summative examinations or other summative assessment.
  • For the summative examinations, reassessment consists of a reassessment MCQ examination.
  • For the written assignment, learners will be required to resubmit the assessment for the component they have failed addressing the inadequacies that have been identified.
  • Learners with recurrent reassessments or who fail a reassessment will be required to meet with the Phase Lead or a delegate, and the Learner Well-being Consultant if the learner so wishes, to support the learner’s academic needs.
  • Learners who achieve less than 70% on two or more summative examinations will be will be notified and provided with academic success resources. The learner may meet with the Phase Lead or a delegate, and the Learner Well-being Consultant if the learner so wished, to further support the learner’s academic needs.
  • A learner may be reassessed for any failed assessment only once.
  • The maximum mark for a reassessment is 70% or, if applicable, the Burr pass mark in the case of the written summative examinations.

Learners may defer examinations with prior approval from the Phase Lead through the deferred examination and assessment procedure. The Summative Assessment Procedure for Phases 1-3 states “Learners seeking to defer a summative MCQ examination or other assessment must follow the Undergraduate Medical Education Deferred Examination Policy.”

If a learner is prevented from completing an assignment by the listed due date, they must follow the procedure outlined in the Undergraduate Medical Education Deferred Examination Policy and request a deferral of the assessment. Where possible, learners must make their request prior to the listed due date of the assignment. If a learner fails to submit a deferral request, any assignment submitted up to two days after the listed due date is considered late and the maximum mark the assignment can receive is 70%. Assignments which are submitted more than two days after the listed due date without a submitted deferral request, will not be accepted for grading unless extenuating circumstances exist and at the discretion of the Phase Lead. Learners are encouraged to seek support from the Learner Well-being Consultants, especially if circumstances arise which may impact a learner’s ability to complete assignments on time.

Version: June 9, 2023
Reviewed by SAS: May 24, 2023
Approved by UGMS: June 21, 2023